| Literature DB >> 29925498 |
Jingsong Zhao1, Nageen Mir2, Nicole Ackermann2, Kimberly A Kaphingst1,3, Mary C Politi2.
Abstract
BACKGROUND: The rate of uninsured people has decreased dramatically since the Affordable Care Act was passed. To make an informed decision, consumers need assistance to understand the advantages and disadvantages of health insurance plans. The Show Me Health Plans Web-based decision support tool was developed to improve the quality of health insurance selection. In response to the promising effectiveness of Show Me Health Plans in a randomized controlled trial (RCT) and the growing need for Web-based health insurance decision support, the study team used expert recommendations for dissemination and implementation, engaged external stakeholders, and made the Show Me Health Plans tool available to the public.Entities:
Keywords: Affordable Care Act; health insurance decision aid; health literacy; public health
Mesh:
Year: 2018 PMID: 29925498 PMCID: PMC6031902 DOI: 10.2196/jmir.9829
Source DB: PubMed Journal: J Med Internet Res ISSN: 1438-8871 Impact factor: 5.428
Key expert recommendations for implementing evidence-based interventions.
| Recommendation | Strategies | Implementation examples |
| Develop stakeholder interrelationships | Identify and prepare champions Build a coalition Identify and prepare champions Use advisory boards and workgroups | The study team built up coalitions with local health nonprofit organizations, community action agencies, and local health care centers and departments throughout the randomized controlled trial and dissemination phases These community partners were regularly updated on study findings, received updated website information for their use, and continued to communicate with the study team about health insurance reform and decision support |
| Train and educate stakeholders | Conduct educational meetings Conduct educational outreach visits Develop educational materials Inform local opinion leaders | Several strategies were utilized to educate stakeholders, including developing educational materials, conducting educational meetings and outreach visits, and informing local opinion leaders |
| Use evaluative and iterative strategies | Assess for readiness and identify barriers and facilitators Conduct local needs assessment | Local needs assessments were conducted to collect information on the SMHPa website The study team assessed the likelihood of adoption and implementation of the website, along with potential barriers and facilitators to implementation |
| Adapt and tailor to context | Promote adaptability Tailor strategies | Website changes made to the tool adapted based on collected feedback |
| Engage consumers | Use mass media | SMHP was featured on local television news, shared via social media, and shared via electronic newsletters to reach large number of consumers and health policy experts |
aSMHP: Show Me Health Plans.
Demographics of users from the dissemination and randomized controlled trial (RCT) phases.
| Variable | Dissemination phase | RCT phase | Test statistic | |||||
| Agea (n=386), mean (SD) | 43.6 (14.4) | 43.1 (13.2) | –0.4b | .69 | ||||
| Male | 162 (43.3) | 67 (40.9) | 0.28c | .59 | ||||
| Female | 212 (56.7) | 97 (59.1) | ||||||
| St. Louis City or County | 196 (52.4) | 152 (92.7) | 81.0c | <.0001 | ||||
| Other | 178 (47.6) | 12 (7.3) | ||||||
| Incomed (n= 337), mean (SD) | 40,523.20 (38,867) | 30,407.01 (54,402) | –2.13b | .03 | ||||
| <100% | 45 (13.5) | 72 (43.9) | 63.6c | <.0001 | ||||
| 100%-249% | 152 (45.5) | 64 (39.0) | ||||||
| 250%-399% | 79 (23.7) | 15 (9.2) | ||||||
| ≥ | 58 (17.4) | 13 (7.9) | ||||||
| 0 | 149 (42.6) | 68 (41.5) | 0.06c | .81 | ||||
| ≥1 | 201 (57.4) | 96 (58.5) | ||||||
an=386 (dissemination phase); n=164 (RCT).
bRefers to t values.
cRefers to χ2 values.
dn=337 (dissemination phase); n=164 (RCT). All values in US $.
Time spent using the Show Me Health Plans (SMHP) tool by users in the dissemination and the randomized controlled trial (RCT) phases.
| Variable | Dissemination phasea | RCT phase | Wilcoxon rank sum, |Z| approximation | ||||||
| n | Median time in sec (IQRb) | Range (sec) | n | Median time in sec (IQR) | Range (sec) | ||||
| 1069 | 7.0 (20.0) | 1-1751 | 164 | 19.0 (22.5) | 5-260 | 8.78 | <.001 | ||
| 488 | 75.5 (228.5) | 1-4967 | 164 | 284.5 (245.0) | 26-2328 | 9.67 | <.001 | ||
| 362 | 116.0 (217.0) | 1-3081 | 164 | 383.5 (217.5) | 144-1685 | 14.38 | <.001 | ||
| 459 | 132 (167.0) | 1-4085 | 164 | 279.0 (171.5) | 94-1013 | 10.19 | <.001 | ||
| 331 | 138 (324) | 1-8319 | 164 | 180.5 (292.5) | 18-7662 | 4.07 | <.001 | ||
| All includedd | 1069 | 0.9 (7.5) | 0.02-189.1 | 164 | 21.5 (15.1) | 6.3-175.1 | 17.0 | <.001 | |
| Completed entire toold | 130 | 17.0 (17.8) | 3.5-189.1 | 164 | 21.5 (15.1) | 6.3-175.1 | 3.24 | .0012 | |
| At least started each sectiond | 229 | 12.2 (15.6) | 1.0-189.1 | 164 | 21.5 (15.1) | 6.3-175.1 | 7.27 | <.001 | |
aOnly users with greater than zero seconds time are included in time calculations (ie, those who just clicked are not included).
bIQR: interquartile range.
cTesting difference in time between dissemination and RCT phases.
dValues refer to overall time; times are expressed in minutes.
Importance ranking between the dissemination and randomized controlled trial (RCT) phases.
| Question | Dissemination phase | RCT phase | Wilcoxon rank sum, |Z| approximation | ||||||||
| n | Meana (SD) | Median (IQRb) | n | Meana (SD) | Median (IQR) | ||||||
| Cost of health insurance premium | 182 | 4.5 (0.9) | 5.0 (1.0) | 164 | 4.5 (0.9) | 5.0 (1.0) | 0.49 | .62 | |||
| Cost of deductible | 182 | 4.3 (1.0) | 5.0 (1.0) | 164 | 4.4 (0.9) | 5.0 (1.0) | 0.13 | .89 | |||
| Cost of doctor visits | 173 | 4.0 (1.1) | 4.0 (2.0) | 164 | 4.3 (1.0) | 5.0 (1.0) | 2.99 | .003 | |||
| Cost of prescription pills or medicine | 173 | 4.1 (1.1) | 4.0 (2.0) | 164 | 4.4 (1.0) | 5.0 (1.0) | 3.01 | .003 | |||
| Choice of doctors, including some that are out-of-network | 171 | 4.3 (1.1) | 5.0 (1.0) | 164 | 4.0 (1.2) | 5.0 (2.0) | 2.82 | .005 | |||
| Cost of out-of-network care | 173 | 3.2 (1.4) | 3.0 (3.0) | 164 | 4.0 (1.2) | 5.0 (2.0) | 5.45 | <.001 | |||
| Fixed cost for tests or care | 171 | 4.0 (1.1) | 4.0 (2.0) | 164 | 4.4 (0.9) | 5.0 (1.0) | 3.75 | <.001 | |||
| Out-of-pocket maximum | 173 | 4.3 (1.0) | 5.0 (1.0) | 164 | 4.6 (0.8) | 5.0 (1.0) | 2.49 | .01 | |||
| Formulary | 171 | 4.2 (1.2) | 5.0 (2.0) | 164 | 4.3 (1.1) | 5.0 (1.0) | 0.72 | .47 | |||
aImportance of features ranked from least to most important on a scale of 1 (not at all important) to 5 (very important).
bIQR: interquartile range.
Match with preferences and algorithm predictions between the dissemination and randomized controlled trial (RCT) phases.
| Variable | Dissemination phase, n (%) | RCT phase, n (%) | χ2 | ||||||
| Yes | 22 (56.4) | 134 (82.7) | |||||||
| No | 17 (43.6) | 28 (17.3) | |||||||
| Good match | 17 (43.6) | 85 (52.5) | |||||||
| Moderate match | 21 (53.9) | 71 (43.8) | |||||||
| Poor match | 1 (2.6) | 6 (3.7) | |||||||
aTesting difference between dissemination and RCT phases.